ID

27974

Descrição

REGIMS is a registry of the administration, adverse events and benefit of immunotherapeutic agents in patients with Multiple Sclerosis. REGIMS is a project from the Institute of Epidemiology and Social Medicine of the University of Muenster, publication granted by Prof. Dr. Berger. For further information (in German), please view http://campus.uni-muenster.de/index.php?id=6075 or http://www.kompetenznetz-multiplesklerose.de/aktuelle-studien/regims. REGIMS ist ein Immuntherapieregister zur Verbesserung der Arzneimittelsicherheit in der Multiple Sklerose Therapie innerhalb des krankheitsbezogenen Kompetenznetzes MS. Das primäre Ziel von REGIMS ist die Erfassung der Häufigkeit, Charakteristika und Auswirkungen von Nebenwirkungen aktueller und neuer Immuntherapien in der klinischen Routinebehandlung der MS. Sekundäre Ziele sind die Auswertung von Faktoren, die a) mit Nebenwirkungen und b) mit guter Therapie-Adhärenz assoziiert sind. Optional können bei Zustimmung der Patienten Blutproben für die Biobank des KKNMS gesammelt werden. Patienten mit Multipler Sklerose (MS) weisen trotz des chronischen Verlaufs eine große Heterogenität klinischer Symptome, in Befunden der Bildgebung sowie pathophysiologischen Prozessen auf. Faktoren, die zur individuellen Krankheitsprognose beitragen sind kaum bekannt, jedoch hat die Einführung neuer Substanzen die Therapiemöglichkeiten der MS in den letzten Jahren deutlich erweitert. Die Anwendung sogenannter Immuntherapeutika (inklusive der neuen Substanzklasse der Biologika) bietet in der MS-Therapie eine Reihe von Chancen, birgt aber auch Risiken.

Link

http://campus.uni-muenster.de/index.php?id=6075

Palavras-chave

Versões (10)
  1. 07/07/2016 07/07/2016 -
  2. 07/07/2016 07/07/2016 -
  3. 07/07/2016 07/07/2016 -
  4. 11/07/2016 11/07/2016 -
  5. 11/07/2016 11/07/2016 -
  6. 12/07/2016 12/07/2016 -
  7. 03/08/2016 03/08/2016 -
  8. 07/12/2017 07/12/2017 -
  9. 15/03/2021 15/03/2021 - Dr. rer. medic Philipp Neuhaus
  10. 20/09/2021 20/09/2021 -
Titular dos direitos

Institute of Epidemiology and Social Medicine UKM

Transferido a

7 de dezembro de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

REGIMS Multiple Sclerosis Immunotherapy Registry Version 2016

Alemão Inglês

Follow Up Medication Change

9 Formulários  
Medication change
Descrição

Medication change

Alias
UMLS CUI-1
C0580105
Which changes in the MS therapy have been carried out since the last visit?
Descrição

VerlModChange

Tipo de dados

integer

Alias
UMLS CUI [1]
C2169461
The active ingredient has been stopped?
Descrição

Abgesetzter Wirkstoff

Tipo de dados

text

Alias
UMLS CUI [1]
C2169646
If other, what?
Descrição

Anderer abgesetzter Wirkstoff

Tipo de dados

text

Alias
UMLS CUI [1,1]
C2169646
UMLS CUI [1,2]
C1115771
What change? (Please enter.)
Descrição

Andere

Tipo de dados

text

Alias
UMLS CUI [1,1]
C2169461
UMLS CUI [1,2]
C0205394
Reason for change of medication
Descrição

Reason for change of medication

Alias
UMLS CUI-1
C2133636
Reason for cancellation
Descrição

GrundAbbruch

Tipo de dados

integer

Alias
UMLS CUI [1]
C2133636
Please specify other reason
Descrição

Text Anderer Grund

Tipo de dados

text

Alias
UMLS CUI [1,1]
C2133636
UMLS CUI [1,2]
C0205394
Current therapy
Descrição

Current therapy

Alias
UMLS CUI-1
C2827774
UMLS CUI-2
C0026769
Active ingredient
Descrição

Wirkstoff

Tipo de dados

text

Alias
UMLS CUI [1,1]
C2827774
UMLS CUI [1,2]
C0026769
If other active ingredient, please describe
Descrição

curth1a

Tipo de dados

text

Alias
UMLS CUI [1,1]
C2827774
UMLS CUI [1,2]
C0026769
UMLS CUI [1,3]
C0205394
Start: Month/year
Descrição

Please select a day of the respective month. It is applied to only the month and year

Tipo de dados

date

Alias
UMLS CUI [1]
C3173309
UMLS CUI [1]-2
C2827774
UMLS CUI [1]-3
C0026769
Regimen
Descrição

Therapieschema

Tipo de dados

integer

Alias
UMLS CUI [1]
C1276413
Please specify the dose and method of administration
Descrição

andere

Tipo de dados

text

Alias
UMLS CUI [1]
C0001555
Voltar ao início da página

Similar models

Follow Up Medication Change

9 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Medication change
C0580105 (UMLS CUI-1)
Item
Which changes in the MS therapy have been carried out since the last visit?
integer
C2169461 (UMLS CUI [1])
VerlModChange
Code List
Which changes in the MS therapy have been carried out since the last visit?
CL Item
The drug dosage has been increased (1)
CL Item
The drug dose was reduced (2)
CL Item
The therapy was deposed and started new (3)
CL Item
The therapy was discontinued without replacement (4)
CL Item
Another change has been performed (99)
Item
The active ingredient has been stopped?
text
C2169646 (UMLS CUI [1])
curth1
Code List
The active ingredient has been stopped?
CL Item
Alemtuzumab (Lemtrada) (22)
C0383429 (UMLS CUI-1)
CL Item
Azathioprine (2)
C0004482 (UMLS CUI-1)
CL Item
Cyclophosphamide (4)
C0010583 (UMLS CUI-1)
CL Item
Fingolimod (Gilenya) (18)
C1699926 (UMLS CUI-1)
CL Item
Fumarate (BG-12; Tecfidera) (24)
C0058218 (UMLS CUI-1)
CL Item
COPAXONE (Copaxone) (6)
C0289884 (UMLS CUI-1)
CL Item
Immune Globulins (7)
C0021027 (UMLS CUI-1)
CL Item
Interferon ß-1A (Avonex) (19)
C0254119 (UMLS CUI-1)
C0021492 (UMLS CUI-2)
CL Item
Interferon ß-1A SC (Rebif 22 µg, Rebif 44 µg) (20)
C0254119 (UMLS CUI-1)
CL Item
Interferon ß 1SC (Betaseron, Extavia) (21)
C0244713 (UMLS CUI-1)
CL Item
* Medication from a MS study (8)
C0013175 (UMLS CUI-1)
C0013227 (UMLS CUI-2)
CL Item
Methotrexate (9)
C0025677 (UMLS CUI-1)
CL Item
Mitoxantrone (10)
C0026259 (UMLS CUI-1)
CL Item
Natalizumab (Tysabri) (11)
C1172734 (UMLS CUI-1)
CL Item
Rituximab (14)
C0393022 (UMLS CUI-1)
CL Item
Teriflunomide (Aubagio) (23)
C1718383 (UMLS CUI-1)
CL Item
Cortisone (25)
C0010137 (UMLS CUI-1)
CL Item
Others... (99)
C1115771 (UMLS CUI-1)
Anderer abgesetzter Wirkstoff
Item
If other, what?
text
C2169646 (UMLS CUI [1,1])
C1115771 (UMLS CUI [1,2])
Andere
Item
What change? (Please enter.)
text
C2169461 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Item Group
Reason for change of medication
C2133636 (UMLS CUI-1)
Item
Reason for cancellation
integer
C2133636 (UMLS CUI [1])
Therapieende
Code List
Reason for cancellation
CL Item
Side effects (1)
C0559546 (UMLS CUI-1)
(Comment:en)
CL Item
Lack effectiveness (2)
C0235828 (UMLS CUI-1)
(Comment:en)
CL Item
Another reason (99)
C3840932 (UMLS CUI-1)
C0850893 (UMLS CUI-2)
(Comment:en)
Text Anderer Grund
Item
Please specify other reason
text
C2133636 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Item Group
Current therapy
C2827774 (UMLS CUI-1)
C0026769 (UMLS CUI-2)
Item
Active ingredient
text
C2827774 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
curth1
Code List
Active ingredient
CL Item
Alemtuzumab (Lemtrada) (22)
C0383429 (UMLS CUI-1)
CL Item
Azathioprine (2)
C0004482 (UMLS CUI-1)
CL Item
Cyclophosphamide (4)
C0010583 (UMLS CUI-1)
CL Item
Fingolimod (Gilenya) (18)
C1699926 (UMLS CUI-1)
CL Item
Fumarate (BG-12; Tecfidera) (24)
C0058218 (UMLS CUI-1)
CL Item
COPAXONE (Copaxone) (6)
C0289884 (UMLS CUI-1)
CL Item
Immune Globulins (7)
C0021027 (UMLS CUI-1)
CL Item
Interferon ß-1A (Avonex) (19)
C0254119 (UMLS CUI-1)
C0021492 (UMLS CUI-2)
CL Item
Interferon ß-1A SC (Rebif 22 µg, Rebif 44 µg) (20)
C0254119 (UMLS CUI-1)
CL Item
Interferon ß 1SC (Betaseron, Extavia) (21)
C0244713 (UMLS CUI-1)
CL Item
* Medication from a MS study (8)
C0013175 (UMLS CUI-1)
C0013227 (UMLS CUI-2)
CL Item
Methotrexate (9)
C0025677 (UMLS CUI-1)
CL Item
Mitoxantrone (10)
C0026259 (UMLS CUI-1)
CL Item
Natalizumab (Tysabri) (11)
C1172734 (UMLS CUI-1)
CL Item
Rituximab (14)
C0393022 (UMLS CUI-1)
CL Item
Teriflunomide (Aubagio) (23)
C1718383 (UMLS CUI-1)
CL Item
Cortisone (25)
C0010137 (UMLS CUI-1)
CL Item
Others... (99)
C1115771 (UMLS CUI-1)
curth1a
Item
If other active ingredient, please describe
text
C2827774 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
curth1ab
Item
Start: Month/year
date
C3173309 (UMLS CUI [1])
C2827774 (UMLS CUI [1]-2)
C0026769 (UMLS CUI [1]-3)
Item
Regimen
integer
C1276413 (UMLS CUI [1])
TherapieSchema
Code List
Regimen
CL Item
Standard (1)
CL Item
Others (99)
andere
Item
Please specify the dose and method of administration
text
C0001555 (UMLS CUI [1])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial